Hayano Lab's Lens Elasticity Finding and Resveratrol
A study co-authored by Hayano Lab members reports that oral resveratrol improved lens elasticity, but the experimental model, dose, and clinical implications remain unknown from the available data.
The Hayano Lab publications page (Japan) includes a study by Nagashima, Sasaki, Amano, Nakamura, Hayano, and Tsubota reporting that oral resveratrol administration improved lens elasticity.
The lab focuses on aging biology. Hayano was co-first author (equal contribution) on a 2023 paper in Cell on loss of epigenetic information as a cause of mammalian aging. Resveratrol, a stilbene polyphenol, was promoted as a SIRT1-activating anti-aging therapy candidate. Later reports described evidence that its apparent SIRT1 activation was assay-dependent and noted poor bioavailability and side effects.
The available data does not establish the experimental model (humans, animals, or isolated tissue), dose, duration, effect size, or publication year of this study. Improved lens elasticity does not by itself mean that vision improved or that an age-related eye condition was treated.
🔗 Hayano Lab publications · Resveratrol on Eternal Search
Sources
[1] Publications | Hayano Lab/早野研究室 | 日本
This edge connects an epigenetics-focused aging lab to a specific resveratrol result in lens mechanics — a narrow but concrete link that sits apart from the lab's primary epigenetic work and from resveratrol's broader contested SIRT1 narrative, making it a genuinely non-obvious graph node worth surfacing.